Intrapleural alteplase in a patient with complicated pleural effusion

Annals of Pharmacotherapy

Volumn 37, Issue 3, 2003, Pages 376-379

  Walker, Charlotte A ^a   Shirk, Mary Beth ^b,c   Tschampel, Marva M ^b,c   Visconti, James A ^b,c   Morand, Brenda R ^d   Guévremont, Chantal ^d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d Ohio State Univ Medical Center ^*

Author keywords

Alteplase; Complicated pleural effusion; Empyema; Fibrinolytics, thrombolytics

Indexed keywords

ALTEPLASE; AZITHROMYCIN; FAMOTIDINE; FIBRINOLYTIC AGENT; STREPTOKINASE; SULTAMICILLIN; UROKINASE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRAIN; DRUG EFFICACY; DRUG SAFETY; EMPYEMA; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; HYPOTENSION; PLEURA EFFUSION; PRIORITY JOURNAL; RESPIRATORY DISTRESS; THORACOCENTESIS; TREATMENT FAILURE;

EID: 0037371009     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1C248     Document Type: Article

References (27)

1. Hamm H, Light RW. Parapneumonic effusion and empyema. Eur Respir J 1997;10:1150-6.
2. Colice GL, Curtis A, Deslauriers J, Heffner J, Light R, Littenberg B, et al. Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest 2000;18:1158-71.
3. de Souza A, Offner PJ, Moore EE, Biffl WL, Haenel JB, Franciose RJ, et al. Optimal management of complicated empyema. Am J Surg 2000;180:507-11.
4. Bouros D, Schiza S, Siafakas N. Utility of fibrinolytic agents for draining intrapleural infections. Semin Respir Infect 1999;14:39-47.
5. Aye RW, Froese DP, Hill LD. Use of purified streptokinase in empyema and hemothorax. Am J Surg 1991;161:560-2.
6. Bouros D, Schiza S, Panagou P, Drositis J, Siafakas N. Role of streptokinase in the treatment of acute loculated parapneumonic pleural effusions and empyema. Thorax 1994;49:852-5.
7. Bouros D, Schiza S, Tzanakis N, Drositis J, Siafakas N. Intrapleural urokinase in the treatment of complicated parapneumonic pleural effusions and empyema. Eur Respir J 1996;9:1656-9.
8. Bouros D, Schiza S, Patsourakis G, Chalkiadakis G, Panagou P, Siafakas N. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions; a prospective, double-blind study. Am J Respir Crit Care Med 1997;155:291-5.
9. Henke CA, Leatherman JW. Intrapleurally administered streptokinase in the treatment of acute loculated nonpurulent parapneumonic effusions. Am Rev Respir Dis 1992;145:680-4.
10. Laisaar T, Puttsepp E, Laisaar V. Early administration of intrapleural streptokinase in the treatment of multiloculated pleural effusions and pleural empyemas. Thorac Cardiovasc Surg 1996;44:252-6.
11. Lee KS, Im JG, Kim YH, Hwang SH, Bae WK, Lee BH. Treatment of thoracic multiloculated empyemas with intracavitary urokinase: a prospective study. Radiology 1991;179:771-5.
12. Moulton JS, Benkert RE, Weisiger KH, Chambers JA. Treatment of complicated pleural fluid collections with image-guided drainage and intracavitary urokinase. Chest 1995;108:1252-9.
13. Robinson LA, Moulton AL, Fleming WH, Alonso A, Galbraith TA. Intrapleural fibrinolytic treatment of multiloculated thoracic empyemas, Ann Thorac Surg 1994;57:803-14.
14. Sahn SA, Davies RJO, Traill ZC, Gleeson FV. Use of fibrinolytic agents in the management of complicated parapneumonic effusions and empyemas. Thorax 1997;52:416-21.
15. Taylor RF, Rubens MB, Pearson MC, Barnes NC. Intrapleural streptokinase in the management of empyema. Thorax 1994;49:856-9.
16. Chin NK, Lim TK. Controlled trial of intrapleural streptokinase in the treatment of pleural empyema and complicated parapneumonic effusions. Chest 1997;111:275-9.
17. Davies RJ, Traill ZC, Gleeson FV. Randomized controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax 1997;52:416-21.
18. Bouros D, Schiza S, Tzanakis N, Chalkiadakis G, Drositis J, Siafakas N. Intrapleural urokinase versus normal saline in the treatment of parapneumonic effusions and empyema; a randomized double blind trial. Am J Respir Crit Care Med 1999;159:37-42.
19. Product information. Streptase (streptokinase). Westborough, MA: Astra USA, September 1998.
20. Cada D, Levien T, Baker D. Alteplase. Hosp Pharm 2002;37:148-54.
21. 2002 Drug topics red book. Montvale, NJ: Thomson-Medical Economics. 2002.
22. Corwin HL, Parsonnet KC. Gettinger A. RBC Transfusion in the ICU. Is there a reason? Chest 1995;108:767-71.
23. Godley PJ, Bell RC. Major hemorrhage following administration of intrapleural streptokinase. Chest 1984;86:486-7.
24. Davies CW, Lok S, Davies RJ. The systemic fibrinolytic activity of intrapleural streptokinase. Am J Respir Crit Care Med 1998;157:328-30.
25. Berglin E, Ekroth R, Teger-Nilsson AC, William-Olsson G. Intrapleural instillation of streptokinase effects on systemic fibrinolysis. Thorac Cardiovasc Surgeon 1981;29:124-6.
26. Sugimoto K, Kee ST, Razavi MK, Sze DY, Dake MD, Semba CP. Safety and efficacy of recombinant tissue plasminogen activator (alteplase) to treat loculated pleural effusions. Presented at: 26th Annual Scientific Meeting of the Society of Cardiovascular and Interventional Radiology, San Antonio, TX, March 3, 2001.
27. Thommi G, Shehan C, Bell A, Coughlin N, McLeay M. Intrapleural instilation of TPA in the management of complicated pleural effusions. Chest 2000;118(suppl 4):S164.